Researchers have demonstrated encouraging results in the treatment of Alzheimer’s disease using the experimental drug BAN2401; this treatment significantly slowed clinical cognitive decline and lead to a size reduction in amyloid plaques.
Not able to attend AAIC this year? You can catch up with all the action from today with our daily video, best of social media and the biggest headlines.
Results from AAIC have revealed significant reductions in the risk of MCI and the combination of MCI and dementia through lowering systolic blood pressure.
Today was the third day of AAIC, with more fascinating talks and exciting posters. You can catch up on our daily update here with a focus on early careers.
Researchers at AAIC have reported new data on how the gut microbiome and lipid metabolism may influence Alzheimer’s and other brain diseases.
Research presented at AAIC 2018 highlights the challenges and successes of both drug and non-drug treatments for non-cognitive symptoms experienced by individuals with Alzheimer’s disease.
Today was the second day of AAIC, with more fascinating talks and exciting posters. You can catch up on the highlights, as well as the latest headlines and the best of social media in our daily update.
Research presented at AAIC reveals the development of the National Strategy and how community based outreach increases participation in Alzheimer’s research.
Researchers have used virtual reality technology to provide high school students an understanding of life with dementia; this will prepare them for interaction with older adults with Alzheimer’s and improve empathy for adults with the disease.
Research presented at AAIC has highlighted sex differences associated with dementia and Alzheimer’s disease across the life course, including the first ever large-scale study of reproductive history and dementia risk in women.
